Delta Financial Group Inc. Buys Shares of 4,696 Church & Dwight Co., Inc. (NYSE:CHD)

Delta Financial Group Inc. purchased a new position in Church & Dwight Co., Inc. (NYSE:CHD - Free Report) during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The firm purchased 4,696 shares of the company's stock, valued at approximately $492,000.

Other large investors also recently modified their holdings of the company. Amalgamated Bank increased its position in shares of Church & Dwight by 0.8% during the 3rd quarter. Amalgamated Bank now owns 50,056 shares of the company's stock valued at $5,242,000 after purchasing an additional 394 shares during the last quarter. Board of the Pension Protection Fund bought a new stake in Church & Dwight during the 4th quarter valued at approximately $639,000. Oddo BHF Asset Management Sas bought a new stake in shares of Church & Dwight in the 3rd quarter worth about $5,934,000. Citigroup Inc. raised its position in shares of Church & Dwight by 9.1% during the 3rd quarter. Citigroup Inc. now owns 337,738 shares of the company's stock valued at $35,368,000 after buying an additional 28,129 shares in the last quarter. Finally, Financial Enhancement Group LLC lifted its holdings in shares of Church & Dwight by 456.2% in the 4th quarter. Financial Enhancement Group LLC now owns 60,585 shares of the company's stock valued at $6,232,000 after acquiring an additional 49,693 shares during the last quarter. Institutional investors own 86.60% of the company's stock.

Church & Dwight Price Performance

Church & Dwight stock traded up $2.50 during midday trading on Monday, reaching $107.83. The company's stock had a trading volume of 799,329 shares, compared to its average volume of 1,550,856. Church & Dwight Co., Inc. has a fifty-two week low of $96.35 and a fifty-two week high of $113.50. The company has a debt-to-equity ratio of 0.51, a quick ratio of 1.24 and a current ratio of 1.70. The firm has a market capitalization of $26.52 billion, a PE ratio of 45.50, a P/E/G ratio of 3.32 and a beta of 0.59. The stock's 50 day simple moving average is $105.35 and its 200 day simple moving average is $104.74.

Church & Dwight (NYSE:CHD - Get Free Report) last released its quarterly earnings data on Friday, January 31st. The company reported $0.77 EPS for the quarter, hitting analysts' consensus estimates of $0.77. Church & Dwight had a return on equity of 20.03% and a net margin of 9.58%. During the same quarter in the prior year, the business posted $0.65 earnings per share. On average, equities research analysts forecast that Church & Dwight Co., Inc. will post 3.7 earnings per share for the current year.

Church & Dwight Increases Dividend

The firm also recently announced a quarterly dividend, which will be paid on Monday, March 3rd. Stockholders of record on Friday, February 14th will be given a dividend of $0.295 per share. This represents a $1.18 dividend on an annualized basis and a dividend yield of 1.09%. This is a positive change from Church & Dwight's previous quarterly dividend of $0.28. The ex-dividend date of this dividend is Friday, February 14th. Church & Dwight's payout ratio is presently 49.79%.

Insider Buying and Selling at Church & Dwight

In other news, EVP Rick Spann sold 39,520 shares of the company's stock in a transaction on Monday, December 2nd. The stock was sold at an average price of $112.00, for a total value of $4,426,240.00. Following the completion of the sale, the executive vice president now owns 4,973 shares in the company, valued at $556,976. This represents a 88.82 % decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available through this link. Also, Director Ravichandra Krishnamu Saligram sold 10,000 shares of the business's stock in a transaction on Monday, December 16th. The stock was sold at an average price of $106.11, for a total value of $1,061,100.00. Following the sale, the director now directly owns 32,500 shares in the company, valued at $3,448,575. This trade represents a 23.53 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold a total of 49,522 shares of company stock valued at $5,487,555 in the last three months. Corporate insiders own 2.00% of the company's stock.

Analyst Ratings Changes

Several research firms have recently issued reports on CHD. TD Cowen raised their price objective on Church & Dwight from $114.00 to $117.00 and gave the company a "buy" rating in a research note on Monday, November 4th. Barclays increased their target price on shares of Church & Dwight from $90.00 to $93.00 and gave the company an "underweight" rating in a research note on Tuesday, February 4th. Stifel Nicolaus lifted their price target on shares of Church & Dwight from $103.00 to $105.00 and gave the stock a "hold" rating in a research note on Monday, February 3rd. Truist Financial lifted their target price on Church & Dwight from $110.00 to $115.00 and gave the stock a "buy" rating in a research report on Monday, February 3rd. Finally, Piper Sandler decreased their price objective on shares of Church & Dwight from $128.00 to $126.00 and set an "overweight" rating for the company in a research report on Monday, February 3rd. Two equities research analysts have rated the stock with a sell rating, seven have assigned a hold rating and eight have assigned a buy rating to the stock. Based on data from MarketBeat.com, the company currently has an average rating of "Hold" and an average price target of $111.47.

Church & Dwight Company Profile

Church & Dwight Co, Inc engages in the development, manufacture, and marketing of household, personal care, and specialty products. It operates through the following segments: Consumer Domestic, Consumer International, Specialty Products, and Corporate. The Consumer Domestic segment offers household products, such as laundry detergents, fabric softener sheets, cat litter, and household cleaning products, and personal care products including antiperspirants, oral care products, depilatories, reproductive health products, oral analgesics, nasal saline moisturizers, and dietary supplements.